{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:54:01Z","timestamp":1790787241662,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicon"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.toxicon.2012.11.025","type":"journal-article","created":{"date-parts":[[2012,12,5]],"date-time":"2012-12-05T18:53:12Z","timestamp":1354733592000},"page":"115-128","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":119,"special_numbering":"C","title":["Evidence-based review and assessment of botulinum neurotoxin for the treatment of adult spasticity in the upper motor neuron syndrome"],"prefix":"10.1016","volume":"67","author":[{"given":"Alberto","family":"Esquenazi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Albanese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael B.","family":"Chancellor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elie","family":"Elovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen R.","family":"Segal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher P.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony B.","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.toxicon.2012.11.025_bib1","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/00004356-199603000-00006","article-title":"Incidence of secondary complications in spinal cord injury","volume":"19","author":"Anson","year":"1996","journal-title":"Int. J. Rehabil. Res."},{"key":"10.1016\/j.toxicon.2012.11.025_bib2","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1046\/j.1468-1331.2001.00277.x","article-title":"A randomized, double-blind, placebo-controlled study of the efficacy and safety of botulinum toxin type A in upper limb spasticity in patients with stroke","volume":"8","author":"Bakheit","year":"2001","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.toxicon.2012.11.025_bib3","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1161\/01.STR.31.10.2402","article-title":"A randomized, double-blind, placebo-controlled, dose-ranging study to compare the efficacy and safety of three doses of botulinum toxin type A (Dysport) with placebo in upper limb spasticity after stroke","volume":"31","author":"Bakheit","year":"2000","journal-title":"Stroke"},{"key":"10.1016\/j.toxicon.2012.11.025_bib4","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1600-0404.2010.01354.x","article-title":"Efficacy and safety of NT 201 for upper limb spasticity of various etiologies \u2013 a randomized parallel-group study","volume":"122","author":"Barnes","year":"2010","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.toxicon.2012.11.025_bib5","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1177\/0888439002250449","article-title":"Spasticity in multiple sclerosis","volume":"17","author":"Barnes","year":"2003","journal-title":"Neurorehabil. Neural Repair"},{"key":"10.1016\/j.toxicon.2012.11.025_bib6","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1136\/jnnp.69.2.217","article-title":"Impact of botulinum toxin type A on disability and carer burden due to arm spasticity after stroke: a randomised double blind placebo controlled trial","volume":"69","author":"Bhakta","year":"2000","journal-title":"J. Neurol. Neurosurg. Psychiatr."},{"key":"10.1016\/j.toxicon.2012.11.025_bib7","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1056\/NEJMoa011892","article-title":"Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after a stroke","volume":"347","author":"Brashear","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.toxicon.2012.11.025_bib8","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.apmr.2003.08.077","article-title":"Botulinum toxin type B in upper-limb poststroke spasticity: a double-blind, placebo-controlled trial","volume":"85","author":"Brashear","year":"2004","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"10.1016\/j.toxicon.2012.11.025_bib9","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.apmr.2003.10.015","article-title":"Dose-dependent response to intramuscular botulinum toxin type A for upper-limb spasticity in patients after a stroke","volume":"85","author":"Childers","year":"2004","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"10.1016\/j.toxicon.2012.11.025_bib10","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1080\/09638280701568296","article-title":"Pharmacology of therapeutic botulinum toxin preparations","volume":"29","author":"Dressler","year":"2007","journal-title":"Disabil. Rehabil."},{"key":"10.1016\/j.toxicon.2012.11.025_bib11","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1097\/01.PHM.0000141127.63160.3E","article-title":"Instrumented assessment of muscle overactivity and spasticity with dynamic polyelectromyographic and motion analysis for treatment planning","volume":"83","author":"Esquenazi","year":"2004","journal-title":"Am. J. Phys. Med. Rehabil."},{"key":"10.1016\/j.toxicon.2012.11.025_bib12","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1111\/j.1468-1331.2010.03084.x","article-title":"Does the treatment of spastic equinovarus deformity following stroke with botulinum toxin increase gait velocity? A systematic review and meta-analysis","volume":"17","author":"Foley","year":"2010","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.toxicon.2012.11.025_bib13","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1177\/135245859800400508","article-title":"A questionnaire to assess neurological impairment in multiple sclerosis","volume":"4","author":"Goodin","year":"1998","journal-title":"Mult. Scler."},{"key":"10.1016\/j.toxicon.2012.11.025_bib14","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.apmr.2008.04.030","article-title":"Botulinum toxin dilution and endplate targeting in spasticity: a double-blind controlled study","volume":"90","author":"Gracies","year":"2009","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"10.1016\/j.toxicon.2012.11.025_bib15","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1191\/026921598668275996","article-title":"Botulinum toxin type A and short-term electrical stimulation in the treatment of upper limb flexor spasticity after stroke: a randomized, double-blind, placebo-controlled trial","volume":"12","author":"Hesse","year":"1998","journal-title":"Clin. Rehabil."},{"key":"10.1016\/j.toxicon.2012.11.025_bib16","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1136\/jnnp.68.6.707","article-title":"Botulinum toxin (Dysport) treatment of hip adductor spasticity in multiple sclerosis: a prospective, randomised, double blind, placebo controlled, dose ranging study","volume":"68","author":"Hyman","year":"2000","journal-title":"J. Neurol. Neurosurg. Psychiatr."},{"key":"10.1016\/j.toxicon.2012.11.025_bib17","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/sj.sc.3100494","article-title":"Secondary conditions following spinal cord injury in a population-based sample","volume":"36","author":"Johnson","year":"1998","journal-title":"Spinal Cord"},{"key":"10.1016\/j.toxicon.2012.11.025_bib18","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1007\/s00415-010-5526-3","article-title":"Botulinum toxin type A in post-stroke lower limb spasticity: a multicenter, double-blind, placebo-controlled trial","volume":"257","author":"Kaji","year":"2010","journal-title":"J. Neurol."},{"key":"10.1016\/j.toxicon.2012.11.025_bib19","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1185\/03007995.2010.497103","article-title":"Botulinum toxin type A in post-stroke upper limb spasticity","volume":"26","author":"Kaji","year":"2010","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.toxicon.2012.11.025_bib20","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/WNF.0b013e3181b13308","article-title":"Efficacy and safety of botulinum neurotoxin NT 201 in poststroke upper limb spasticity","volume":"32","author":"Kanovsky","year":"2009","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.toxicon.2012.11.025_bib21","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1468-1331.2008.02114.x","article-title":"Prevalence of disabling spasticity 1 year after first-ever stroke","volume":"15","author":"Lundstrom","year":"2008","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.toxicon.2012.11.025_bib22","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S1047-9651(03)00093-7","article-title":"Muscle overactivity and movement dysfunction in the upper motoneuron syndrome","volume":"14","author":"Mayer","year":"2003","journal-title":"Phys. Med. Rehabil. Clin. N. Am."},{"key":"10.1016\/j.toxicon.2012.11.025_bib23","first-page":"566","article-title":"Epidemiology of spasticity following traumatic spinal cord injury","volume":"71","author":"Maynard","year":"1990","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"10.1016\/j.toxicon.2012.11.025_bib24","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1097\/00002060-200011000-00009","article-title":"Secondary impairments after spinal cord injury: a population-based study","volume":"79","author":"Noreau","year":"2000","journal-title":"Am. J. Phys. Med. Rehabil."},{"key":"10.1016\/j.toxicon.2012.11.025_bib25","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1159\/000069495","article-title":"A double-blind randomised placebo-controlled evaluation of three doses of botulinum toxin type A (Dysport) in the treatment of spastic equinovarus deformity after stroke","volume":"15","author":"Pittock","year":"2003","journal-title":"Cerebrovasc. Dis."},{"key":"10.1016\/j.toxicon.2012.11.025_bib26","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1136\/jnnp.69.4.499","article-title":"Evaluating the role of botulinum toxin in the management of focal hypertonia in adults","volume":"69","author":"Richardson","year":"2000","journal-title":"J. Neurol. Neurosurg. Psychiatr."},{"key":"10.1016\/j.toxicon.2012.11.025_bib27","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1191\/1352458504ms1085oa","article-title":"Prevalence and treatment of spasticity reported by multiple sclerosis patients","volume":"10","author":"Rizzo","year":"2004","journal-title":"Mult. Scler."},{"key":"10.1016\/j.toxicon.2012.11.025_bib28","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1586\/14737175.3.6.773","article-title":"Botulinum toxin treatment of adult spasticity","volume":"3","author":"Sheean","year":"2003","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.toxicon.2012.11.025_bib29","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1212\/WNL.46.5.1306","article-title":"Botulinum toxin type A in the treatment of upper extremity spasticity: a randomized, double-blind, placebo-controlled trial","volume":"46","author":"Simpson","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.toxicon.2012.11.025_bib30","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1212\/01.wnl.0000311391.00944.c4","article-title":"Assessment: botulinum neurotoxin for the treatment of spasticity (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology","volume":"70","author":"Simpson","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.toxicon.2012.11.025_bib31","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1136\/jnnp.2008.159657","article-title":"Botulinum neurotoxin versus tizanidine in upper limb spasticity: a placebo-controlled study","volume":"80","author":"Simpson","year":"2009","journal-title":"J. Neurol. Neurosurg. Psychiatr."},{"key":"10.1016\/j.toxicon.2012.11.025_bib32","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1016\/S0003-9993(99)90329-5","article-title":"Spasticity after traumatic spinal cord injury: nature, severity, and location","volume":"80","author":"Skold","year":"1999","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"10.1016\/j.toxicon.2012.11.025_bib33","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1191\/026921500666642221","article-title":"A double-blind placebo-controlled study of botulinum toxin in upper limb spasticity after stroke or head injury","volume":"14","author":"Smith","year":"2000","journal-title":"Clin. Rehabil."},{"key":"10.1016\/j.toxicon.2012.11.025_bib34","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1161\/01.STR.0000105386.05173.5E","article-title":"Spasticity after stroke: its occurrence and association with motor impairments and activity limitations","volume":"35","author":"Sommerfeld","year":"2004","journal-title":"Stroke"},{"key":"10.1016\/j.toxicon.2012.11.025_bib35","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1080\/09638280400009360","article-title":"The lowest effective dose of botulinum A toxin in adult patients with upper limb spasticity","volume":"27","author":"Suputtitada","year":"2005","journal-title":"Disabil. Rehabil."},{"key":"10.1016\/j.toxicon.2012.11.025_bib36","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1191\/0269215505cr827oa","article-title":"A randomized controlled trial of botulinum toxin on lower limb spasticity following acute acquired severe brain injury","volume":"19","author":"Verplancke","year":"2005","journal-title":"Clin. Rehabil."},{"key":"10.1016\/j.toxicon.2012.11.025_bib37","first-page":"53","article-title":"A database of self-reported secondary medical problems among VA spinal cord injury patients: its role in clinical care and management","volume":"39","author":"Walter","year":"2002","journal-title":"J. Rehabil. Res. Dev."},{"key":"10.1016\/j.toxicon.2012.11.025_bib38","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1191\/0269215502cr512oa","article-title":"Prevalence of spasticity post stroke","volume":"16","author":"Watkins","year":"2002","journal-title":"Clin. Rehabil."},{"key":"10.1016\/j.toxicon.2012.11.025_bib39","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1080\/02699050400025182","article-title":"Long-term outcome in severe traumatic brain injury is significantly influenced by brainstem involvement","volume":"19","author":"Wedekind","year":"2005","journal-title":"Brain Inj."},{"key":"10.1016\/j.toxicon.2012.11.025_bib40","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1159\/000091222","article-title":"Spasticity and its association with functioning and health-related quality of life 18 months after stroke","volume":"21","author":"Welmer","year":"2006","journal-title":"Cerebrovasc. Dis."}],"container-title":["Toxicon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010112008203?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010112008203?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T07:27:02Z","timestamp":1540020422000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041010112008203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":40,"alternative-id":["S0041010112008203"],"URL":"https:\/\/doi.org\/10.1016\/j.toxicon.2012.11.025","relation":{},"ISSN":["0041-0101"],"issn-type":[{"value":"0041-0101","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evidence-based review and assessment of botulinum neurotoxin for the treatment of adult spasticity in the upper motor neuron syndrome","name":"articletitle","label":"Article Title"},{"value":"Toxicon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxicon.2012.11.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}